(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial

BACKGROUND: (1,3)-β-d-Glucan has been widely used in clinical practice for the diagnosis of invasive Candida infections. However, such serum biomarker showed potential to guide antimicrobial therapy in order to reduce the duration of empirical antifungal treatment in critically ill septic patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pascale, Gennaro, Posteraro, Brunella, D’Arrigo, Sonia, Spinazzola, Giorgia, Gaspari, Rita, Bello, Giuseppe, Montini, Luca Maria, Cutuli, Salvatore Lucio, Grieco, Domenico Luca, Di Gravio, Valentina, De Angelis, Giulia, Torelli, Riccardo, De Carolis, Elena, Tumbarello, Mario, Sanguinetti, Maurizio, Antonelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487510/
https://www.ncbi.nlm.nih.gov/pubmed/32891170
http://dx.doi.org/10.1186/s13054-020-03265-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487510/
https://www.ncbi.nlm.nih.gov/pubmed/32891170
http://dx.doi.org/10.1186/s13054-020-03265-y

Ejemplares similares